The frequency of BUB1 gene alterations in melanoma, bladder cancer, and EC was high (frequency > 5%) and the gene alterations mainly included mutations (Fig. S3A), including missense mutations, amplifications and profound deletions. This evidence concerns the gene BUB1 and melanoma.